PLRZ logo

Polyrizon Ltd.

PLRZ
Healthcare|Biotechnology|IL
$11.04
-0.55 (-4.70%)
DCF Value
$0.81
Tangible Book / Share
$12.17
Cash / Share
$8.31
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Sep 28, 2026 (F-1/A). Possible dilution.

Upcoming Data Readouts (1)

Jul 2027
Est. completion
NASeasonal Allergic Rhinitis (SAR)
Evaluation of the Efficacy, Safety, and Tolerability of PL-14 Allergy Blocker Compared to Saline Spray in Patients With Seasonal Allergic Rhinitis
NCT07588672n=120

Recent Press Releases

Polyrizon Announces Successful Completion Enrollment of all 120 Patients in U.S. Clinical Study of NASARIX Allergy Blocker
Oct 27, 2026 · GlobeNewsWire
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
Oct 5, 2026 · GlobeNewsWire
Polyrizon Enrolls First Patient in U.S. Clinical Study of NASARIX (PL-14) Allergy Blocker
Sep 22, 2026 · GlobeNewsWire
Polyrizon Ltd. Announces Closing of $4.0 Million Registered Direct Offering and Private Placement
Sep 4, 2026 · GlobeNewsWire
Polyrizon Ltd. Announces $4.0 Million Registered Direct Offering and Private Placement
Sep 3, 2026 · GlobeNewsWire
Polyrizon Completes All Five U.S. Site Contracts for NASARIX™ First-in-Human Allergy Study
Sep 2, 2026 · GlobeNewsWire
Polyrizon Completes Clinical Site Network for NASARIX™ Study and Advances Toward Patient Enrollment
Aug 20, 2026 · GlobeNewsWire

SEC Filings (105)

Last two years from EDGAR. Insider Form 4s are on the Ownership tab.

FiledFormWhat it isLinks
Oct 27, 20266-KForeign issuer reportDocumentIndex
Oct 7, 2026S-8Employee stock planDocumentIndex
Oct 5, 20266-KForeign issuer reportDocumentIndex
Oct 1, 2026EFFECTDocumentIndex
Sep 28, 2026F-1/AIPO / offering registrationDocumentIndex
Sep 28, 20266-KForeign issuer reportDocumentIndex
Sep 18, 2026F-1IPO / offering registrationDocumentIndex
Sep 10, 2026DDocumentIndex
Sep 4, 20266-KForeign issuer reportDocumentIndex
Sep 4, 20266-KForeign issuer reportDocumentIndex
Sep 4, 2026424B5Offering prospectusDocumentIndex
Aug 20, 20266-KForeign issuer reportDocumentIndex
Aug 14, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Jul 13, 20266-KForeign issuer reportDocumentIndex
Jul 2, 20266-KForeign issuer reportDocumentIndex
Jun 29, 20266-KForeign issuer reportDocumentIndex
Jun 17, 20266-KForeign issuer reportDocumentIndex
Jun 15, 20266-KForeign issuer reportDocumentIndex
Jun 10, 20266-KForeign issuer reportDocumentIndex
Jun 8, 20266-KForeign issuer reportDocumentIndex
Jun 8, 20266-KForeign issuer reportDocumentIndex
Jun 5, 20266-KForeign issuer reportDocumentIndex
May 27, 20266-KForeign issuer reportDocumentIndex
May 13, 20266-KForeign issuer reportDocumentIndex
May 4, 2026EFFECTDocumentIndex
May 4, 20266-KForeign issuer reportDocumentIndex
Apr 30, 2026F-1/AIPO / offering registrationDocumentIndex
Apr 28, 2026SC 13GPassive 5%+ stakeDocumentIndex
Apr 27, 20266-KForeign issuer reportDocumentIndex
Apr 23, 2026DDocumentIndex
Apr 23, 2026F-1IPO / offering registrationDocumentIndex
Apr 8, 20266-KForeign issuer reportDocumentIndex
Apr 8, 2026424B5Offering prospectusDocumentIndex
Mar 27, 202620-F/AAnnual report (foreign)DocumentIndex
Mar 25, 202620-FAnnual report (foreign)DocumentIndex
Mar 17, 20266-KForeign issuer reportDocumentIndex
Mar 16, 2026SC 13GPassive 5%+ stakeDocumentIndex
Mar 10, 20266-KForeign issuer reportDocumentIndex
Mar 9, 2026SC 13G/APassive 5%+ stakeDocumentIndex
Feb 26, 20266-KForeign issuer reportDocumentIndex